Argon plasma surface modification promotes the therapeutic angiogenesis and tissue formation of tissue-engineered scaffolds in vivo by adipose-derived stem cells

• Published in: Stem cell research & therapy Vol. 10; no. 1; p. 110
• Main Authors: Griffin, M F, Naderi, N, Kalaskar, D M, Seifalian, A M, Butler, P E
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 29-03-2019; BioMed Central; BMC
• Subjects: Adipose-derived stem cell; Angiogenesis; Argon; Argon plasma coagulation; Biodegradability; Biological products; Biomaterials; Biomedical materials; Blood platelets; Bone marrow; Cancer; CD45 antigen; Cell adhesion & migration; Congenital diseases; Fibroblasts; Gene expression; Genetic disorders; Immune response; Immunohistochemistry; Infection; Medical research; Nanocomposites; Neovascularization; Plasma; Plasma surface modification; Polyurethane; Polyurethanes; Stem cells; Tissue engineering; Tissue integration; Transplants & implants; Vascular endothelial growth factor; Vascular-derived growth factor; Tissue integration; Angiogenesis; Vascular-derived growth factor; Plasma surface modification; Adipose-derived stem cell
• ISSN: 1757-6512; 1757-6512
• DOI: 10.1186/s13287-019-1195-z

Synthetic implants are being used to restore injured or damaged tissues following cancer resection and congenital diseases. However, the survival of large tissue implant replacements depends on their ability to support angiogenesis that if limited, causes extrusion and infection of the implant. This study assessed the beneficial effect of platelet-rich plasma (PRP) and adipose-derived stem cells (ADSCs) on synthetic biomaterials in combination with argon plasma surface modification to enhance vascularisation of tissue-engineered constructs.
Non-biodegradable polyurethane scaffolds were manufactured and modified with plasma surface modification using argon gas (PM). Donor rats were then used to extract ADSCs and PRP to modify the scaffolds further. Scaffolds with and without PM were modified with and without ADSCs and PRP and subcutaneously implanted in the dorsum of rats for 3 months. After 12 weeks, the scaffolds were excised and the degree of tissue integration using H&E staining and Masson's trichrome staining, angiogenesis by CD31 and immune response by CD45 and CD68 immunohistochemistry staining was examined.
H&E and Masson's trichrome staining showed PM+PRP+ADSC and PM+ADSC scaffolds had the greatest tissue integration, but there was no significant difference between the two scaffolds (p < 0.05). The greatest vessel formation after 3 months was shown with PM+PRP+ADSC and PM+ADSC scaffolds using CD31 staining compared to all other scaffolds (p < 0.05). The CD45 and CD68 staining was similar between all scaffolds after 3 months showing the ADSCs or PRP had no effect on the immune response of the scaffolds.
Argon plasma surface modification enhanced the effect of adipose-derived stem cells effect on angiogenesis and tissue integration of polyurethane scaffolds. The combination of ADSCs and argon plasma modification may improve the survival of large tissue implants for regenerative applications.